Transradial Access Products Market Report 2026

Transradial Access Products Market Overview

• Transradial Access Products market size has reached to $2.47 billion in 2025 • Expected to grow to $4.39 billion in 2030 at a compound annual growth rate (CAGR) of 12.2% • Growth Driver: Rising Cardiovascular Disease Prevalence Drives Growth In The Market • Market Trend: Advancements In Peripheral Support Catheters Driving The Market • North America was the largest region in 2025.

What Is Covered Under Transradial Access Products Market?

Transradial access products are medical devices used to gain access to the circulatory system through the radial artery in the wrist, commonly for procedures such as coronary angiography and angioplasty. Transradial access is utilized in medical procedures, primarily in cardiology, by gaining access to the circulatory system through the radial artery in the wrist. The main types of products in the transradial access products are catheters, guidewires, sheaths, and other products. A catheter is a flexible medical tube used for fluid delivery, medication administration, or diagnostics in minimally invasive procedures. These products are used for various applications, such as diagnostics and interventions, drug administration, blood transfusions, and other procedures. They are utilized by various end users, including hospitals and clinics, ambulatory surgical centers, and other healthcare facilities.

What Is The Transradial Access Products Market Growth Forecast?

The transradial access products market size is expected to see rapid growth in the next few years. It will grow to $4.39 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to rising minimally invasive cardiology, preference for outpatient procedures, innovation in guidewire materials, patient safety focus, global cardiac procedure growth. Major trends in the forecast period include shift from femoral to radial access, reduced post-procedure complications, growth in interventional cardiology, improved hemostatic device designs, faster patient recovery times.

Global Transradial Access Products Market Segmentation

1) By Product: Catheter, Guidewire, Sheath, Other Products 2) By Application: Diagnostic And Interventional, Drug Administration, Blood Transfusion, Other Applications 3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Other End Users Subsegments: 1) By Catheter: Diagnostic Catheters, Guiding Catheters, Balloon Catheters 2) By Guidewire: Hydrophilic Guidewires, Nitinol Guidewires, Stainless Steel Guidewires 3) By Sheath: Introducer Sheaths, Radial Sheath Sets, Hydrophilic-Coated Sheaths 4) By Other Products: Hemostatic Devices, Compression Bands, Vascular Closure Devices

What Is The Driver Of The Transradial Access Products Market?

The increasing prevalence of cardiovascular diseases is expected to propel the growth of the transradial access products market going forward. Cardiovascular diseases refer to a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart failure, and stroke. The increasing prevalence of cardiovascular diseases is attributed to factors such as sedentary lifestyles, unhealthy diets, obesity, smoking, excessive alcohol consumption, and aging populations, leading to higher incidences of hypertension, diabetes, and other risk factors. Transradial access products improve cardiovascular disease treatment by enabling minimally invasive catheterization procedures, reducing complications, enhancing patient comfort, and accelerating recovery times. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, up 4.0% from 224.4 per 100,000 in 2023. Therefore, the increasing prevalence of cardiovascular diseases is driving the transradial access products industry.

Key Players In The Global Transradial Access Products Market

Major companies operating in the transradial access products market are Johnson & Johnson, Abbott Vascular, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, Teleflex Incorporated, Cook Medical, Biotronik SE & Co., Merit Medical Systems Inc., Penumbra Inc., Angiodynamics Inc., Oscor Inc., Asahi Intecc Co. Ltd., Nipro Medical Corporation, Vascular Solutions Inc., Cardinal Health Inc., BD Interventional, B. Braun Melsungen AG, Medline Industries LP

Global Transradial Access Products Market Trends and Insights

Major companies operating in the transradial access products market are focusing on developing innovative products such as peripheral support catheter to enhance procedural efficiency and improve patient outcomes. A peripheral support catheter refers to a specialized catheter designed to provide additional support and stability during complex peripheral vascular interventions, such as crossing chronic total occlusions or navigating tortuous arteries. For instance, in December 2024, Terumo Interventional Systems (TIS), a division of Terumo Corporation, a US-based medical technology, launched Its R2P NaviCross Peripheral Support Catheter. This provides a wide range of interventional products, including catheters, guidewires, sheaths, and other devices used in cardiovascular and peripheral procedures. The R2P NaviCross Peripheral Support Catheter is designed to support guidewires and improve navigation during complex peripheral vascular procedures, helping to cross difficult lesions and access challenging areas in peripheral arteries.

What Are Latest Mergers And Acquisitions In The Transradial Access Products Market?

In May 2024, Merit Medical Systems, Inc., a US-based medical device company focused on interventional and diagnostic procedures, acquired Endovascular Technologies for an undisclosed amount. With this acquisition, Merit Medical aims to strengthen and broaden its transradial access product portfolio, enhance its offering in interventional cardiology, and expand its presence in the global transradial access products market by integrating Endovascular Technologies’ specialized radial-access solutions into its existing radial sheath and compression device lines. Endovascular Technologies is a medical device company specializing in transradial access devices.

Regional Outlook

North America was the largest region in the transradial access products market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Transradial Access Products Market?

The transradial access products consist of sales of hemostasis devices, radial compression devices, stents, angioplasty balloons, and guidewires. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.